211 related articles for article (PubMed ID: 22971998)
1. Associations of type 2 diabetes and diabetes treatment with breast cancer risk and mortality: a population-based cohort study among British women.
Redaniel MT; Jeffreys M; May MT; Ben-Shlomo Y; Martin RM
Cancer Causes Control; 2012 Nov; 23(11):1785-95. PubMed ID: 22971998
[TBL] [Abstract][Full Text] [Related]
2. Associations between diabetes medication use and risk of second breast cancer events and mortality.
Calip GS; Yu O; Hoskins KF; Boudreau DM
Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
[TBL] [Abstract][Full Text] [Related]
3. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
Calip GS; Yu O; Elmore JG; Boudreau DM
Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
[TBL] [Abstract][Full Text] [Related]
4. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
Kowall B; Stang A; Rathmann W; Kostev K
Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
[TBL] [Abstract][Full Text] [Related]
5. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with sulfonylureas and metformin and the prevention of death in type 2 diabetes: a nested case-control study.
Azoulay L; Schneider-Lindner V; Dell'aniello S; Schiffrin A; Suissa S
Pharmacoepidemiol Drug Saf; 2010 Apr; 19(4):335-42. PubMed ID: 20052677
[TBL] [Abstract][Full Text] [Related]
7. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
[TBL] [Abstract][Full Text] [Related]
8. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer.
Holden SE; Jenkins-Jones S; Morgan CL; Schernthaner G; Currie CJ
Diabetes Obes Metab; 2015 Apr; 17(4):350-62. PubMed ID: 25399739
[TBL] [Abstract][Full Text] [Related]
9. Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
Izano M; Satariano WA; Hiatt RA; Braithwaite D
Cancer Med; 2015 Feb; 4(2):315-24. PubMed ID: 25511535
[TBL] [Abstract][Full Text] [Related]
10. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort.
Baur DM; Klotsche J; Hamnvik OP; Sievers C; Pieper L; Wittchen HU; Stalla GK; Schmid RM; Kales SN; Mantzoros CS
Metabolism; 2011 Oct; 60(10):1363-71. PubMed ID: 21081242
[TBL] [Abstract][Full Text] [Related]
12. [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
[TBL] [Abstract][Full Text] [Related]
13. Association of type 2 diabetes genetic variants with breast cancer survival among Chinese women.
Bao PP; Zhao ZG; Gao YT; Zheng Y; Zhang B; Cai H; Zheng W; Shu XO; Lu W
PLoS One; 2015; 10(2):e0117419. PubMed ID: 25679392
[TBL] [Abstract][Full Text] [Related]
14. Mortality in people with type 2 diabetes in the UK.
Mulnier HE; Seaman HE; Raleigh VS; Soedamah-Muthu SS; Colhoun HM; Lawrenson RA
Diabet Med; 2006 May; 23(5):516-21. PubMed ID: 16681560
[TBL] [Abstract][Full Text] [Related]
15. Active smoking and breast cancer risk: original cohort data and meta-analysis.
Gaudet MM; Gapstur SM; Sun J; Diver WR; Hannan LM; Thun MJ
J Natl Cancer Inst; 2013 Apr; 105(8):515-25. PubMed ID: 23449445
[TBL] [Abstract][Full Text] [Related]
16. Metformin use and survival after colorectal cancer: A population-based cohort study.
Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
[TBL] [Abstract][Full Text] [Related]
17. Type 2 diabetes, breast cancer specific and overall mortality: Associations by metformin use and modification by race, body mass, and estrogen receptor status.
Lee KN; Torres MA; Troeschel AN; He J; Gogineni K; McCullough LE
PLoS One; 2020; 15(5):e0232581. PubMed ID: 32369516
[TBL] [Abstract][Full Text] [Related]
18. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.
Bannister CA; Holden SE; Jenkins-Jones S; Morgan CL; Halcox JP; Schernthaner G; Mukherjee J; Currie CJ
Diabetes Obes Metab; 2014 Nov; 16(11):1165-73. PubMed ID: 25041462
[TBL] [Abstract][Full Text] [Related]
19. Trends in breast cancer incidence among women with type-2 diabetes in British general practice.
Bronsveld HK; Peeters PJHL; de Groot MCH; de Boer A; Schmidt MK; De Bruin ML
Prim Care Diabetes; 2017 Aug; 11(4):373-382. PubMed ID: 28237628
[TBL] [Abstract][Full Text] [Related]
20. Type 2 diabetes and the risk of mortality among patients with prostate cancer.
Bensimon L; Yin H; Suissa S; Pollak MN; Azoulay L
Cancer Causes Control; 2014 Mar; 25(3):329-38. PubMed ID: 24384808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
